MedMira Inc. (TSXV:MIR)

Revenue by Product

Financials in millions CAD. Fiscal year is August - July.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020	Jul 31, 2019	Jul 31, 2018	Jul 31, 2017
Rapid Diagnostic Products	265.09K
Rapid Diagnostic Products Growth	3.49%
Rapid Diagnostic Services	147.48K
Rapid Diagnostic Services Growth	-16.39%

Revenue by Geography

Financials in millions CAD. Fiscal year is August - July.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020	Jul 31, 2019	Jul 31, 2018	Jul 31, 2017
North America	323.65K
North America Growth	-14.74%
Europe	54.94K
Europe Growth	79.01%
Canada	33.98K
Canada Growth	52.83%